Electronimmunocytochemical evidence for the K cell localization of gastric inhibitory polypeptide (GIP) in man
[DOI] [PMC free article] [PubMed] [Google Scholar] 481.Yeom C.J., Chung T., Youn H., Kang K.W., Lee D.S., Chung J.K
Ozempic is not approved for use as a weight loss treatment, for diabetes prevention, or to treat Type 1 diabetes or metabolic syndrome (without a co-diagnosis of Type 2 diabetes)
Both drug classes have demonstrated ability to increase genioglossus muscle activity, thus preventing upper airway collapse during sleep
you lose weight, not playing catch-up afterward
A personalized approach considering individual bone and cardiovascular risk profiles is essential when prescribing GLP-1RAs to women, particularly those with osteoporosis or high cardiovascular risk